Industry news
  • Monkeys with Parkinson


    Transplantation of neurons made from induced pluripotent stem cells show long-term benefit in monkeys with Parkinson's disease One of the last steps before treating patients with an experimental cell therapy for the brain is confirmation that the therapy works in monkeys. Today, scientists at the Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan, report monkeys with Parkinson's disease symptoms show significant improvement over two years after being transplant

  • Stem cell-based spinal cord therapy expanded to more patients


    An experimental therapy to repair spinal cord injury with stem cell-derived tissue is progressing smoothly, according to a leader of that trial who spoke at a conference on stem cell therapy. The Phase 1 safety trialis proceeding with no complications, said Dr. Joseph Ciacci, a University of California San Diego neurosurgeon. The trial is being conducted at the university’sSanford Stem Cell Clinical Center. The conference was held last week at the Sanford Consortium for Regenerative Medicine in

  • Trials of Embryonic Stem Cells to Launch in China


    Studies to treat vision loss and Parkinson's disease are the first to proceed under new regulations in the next few months, surgeons in the Chinese city of Zhengzhou will carefully drill through the skulls of people with Parkinson’s disease and inject 4 million immature neurons derived from human embryonic stem cells into their brains. Then they will patch the patients up, send them home and wait. This will mark the start of the first clinical trial in China using human embryonic stem (ES)

  • New clinical trial to evaluate efficacy of stem cell product in patients disabled with chronic strok


    A clinical trial to evaluate the safety and efficacy of a stem cell product injected directly into the brain to treat chronic motor deficits from ischemic stroke has begun at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth). McGovern Medical School at UTHealth is the only site in Texas and the central south portion of the country to open enrollment for the multi-institutional, phase 2B study - the first in the U.S. for chronic stroke. Surgeries will

  • Scientists unveil the UK's largest resource of human stem cells from healthy donors Powerful resourc


    Reported inNature, one of the largest sets of high quality human induced pluripotent stem cell lines from healthy individuals has been produced by a consortium involving the Wellcome Trust Sanger Institute. Comprehensively annotated and available for independent research, the hundreds of stem cell lines are a powerful resource for scientists studying human development and disease. With collaborative partners from King's College London, the European Bioinformatics Institute, the University o

  • The Beauty of “Mini Brains”


    Lab-grown bundles of brain cells may be the future of drug testing Lab-grown miniature brains are poised to shake up drug testing for everything from Alzheimer’s disease to Zika. Each bundle of human brain cells is so tiny that it could fit on the head of a pin. Researcher Thomas Hartung and his colleagues at Johns Hopkins University created these mini brains using stem cells that, over the course of two months, morph into supporting cells and various types of neurons, which quickly connect to

  • Japanese Man Is First to Receive "Reprogrammed" Stem Cells from Another Person


    World-first transplant to treat macular degeneration could augur rise of iPS cell banksOn March 28, a Japanese man in his 60s became the first person to receive cells derived from induced pluripotent stem (iPS) cells that had been donated by another person.The surgery is expected to set the path for more applications of iPS cell technology, which offers the versatility of embryonic stem cells without the latter’s ethical taint. Banks of iPS cells from diverse donors could make stem cell transpl

Technical Support: 森云科技 | Admin Login